
    
      In this study, we aimed to develop a clinical risk score model, according to the available
      clinical syndromes and commonly laboratory tests, for screening BM among full-term neonates
      in a large-scale retrospective cohort, and prospectively validated the risk score in
      multicenter cohort.
    
  